Literature DB >> 6139099

Symptom checklist syndromes in the general population. Correlations with psychotherapeutic drug use.

E H Uhlenhuth, M B Balter, G D Mellinger, I H Cisin, J Clinthorne.   

Abstract

Using symptom checklists administered on a large scale by survey interviewers in the 1979 National Survey of Psychotherapeutic Drug Use, we developed a method for classifying survey respondents by syndromes. These syndromes had symptoms and other characteristics consistent with their DSM-III diagnostic counterparts and showed one-year prevalence rates in accord with available epidemiologic data: Major Depression, 5.1%; Agoraphobia-Panic, 1.2%; Other Phobia, 2.3%; and Generalized Anxiety, 6.4%. However, the anxiety-related syndromes occurred less frequently than clinical lore might suggest. The data showed a very low rate of antidepressant use and a higher rate of antianxiety agent use among Major Depressives (11% and 23%) and Agoraphobics (8% and 55%). Also noteworthy were the infrequent use of antianxiety agents among respondents with Generalized Anxiety (27%) and the low frequency of both antianxiety (19%) and antidepressant (3%) drug use among persons with high distress who did not qualify for any syndrome. These findings suggest that the majority of persons with serious psychiatric disorders still do not receive treatment or the most appropriate treatment.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6139099     DOI: 10.1001/archpsyc.1983.01790100013001

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  27 in total

Review 1.  The epidemiology of fatigue: more questions than answers.

Authors:  G Lewis; S Wessely
Journal:  J Epidemiol Community Health       Date:  1992-04       Impact factor: 3.710

Review 2.  Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (Part II).

Authors:  D J Greenblatt; J S Harmatz; R I Shader
Journal:  Clin Pharmacokinet       Date:  1991-10       Impact factor: 6.447

3.  [Evaluation and validation of a test of psychological distress in a general population in french Quebec].

Authors:  R Massé; C Poulin; C Dassa; J Lambert; S Bélair; A Battaglini
Journal:  Can J Public Health       Date:  1998 May-Jun

4.  The validity of the French version of the GHQ-28 and PSYDIS in a community sample of 20 year olds in Switzerland.

Authors:  M Bolognini; W Bettschart; M Zehnder-Gubler; L Rossier
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989

5.  Epidemiology of anxiety.

Authors:  I M Marks
Journal:  Soc Psychiatry       Date:  1986

6.  Further studies on the prevalence of isolated sleep paralysis in black subjects.

Authors:  C C Bell; D D Dixie-Bell; B Thompson
Journal:  J Natl Med Assoc       Date:  1986-07       Impact factor: 1.798

7.  Psychological distress among Plains Indian mothers with children referred to screening for Fetal Alcohol Spectrum Disorders.

Authors:  Tassy Parker; Marcello A Maviglia; Phyllis Trujillo Lewis; J Phillip Gossage; Philip A May
Journal:  Subst Abuse Treat Prev Policy       Date:  2010-09-06

8.  Phobia: prevalence and risk factors.

Authors:  J H Boyd; D S Rae; J W Thompson; B J Burns; K Bourdon; B Z Locke; D A Regier
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1990-11       Impact factor: 4.328

Review 9.  A critical review of dimension-specific measures of health-related quality of life in cross-cultural research.

Authors:  M J Naughton; I Wiklund
Journal:  Qual Life Res       Date:  1993-12       Impact factor: 4.147

Review 10.  Treatment considerations for the depressed geriatric medical patient.

Authors:  H G Koenig
Journal:  Drugs Aging       Date:  1991 Jul-Aug       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.